0
0.5
1
1.5
2+
Recovery at day 14
92%
Improvement
Relative Risk
Improvement in pneumon..
83%
HCQ Huang et al. EARLY TREATMENT RCT
Is early treatment with HCQ beneficial for COVID-19?
RCT 22 patients in China (January - February 2020)
Trial compares with lopinavir/ritonavir, results vs. placebo may differ
Improved recovery with HCQ (p=0.015)
c19hcq.org
Huang et al., J. Molecular Cell Biolog.., Apr 2020
Favors HCQ
Favors lopinavir/ri..